Syngene Limited (External organisation)

Activity: Industry, Government and Philanthropy Engagement and PartnershipsPatentsPatent


Insulin analogues

Abstract: A dicarba analogue of insulin comprising an A-chain and a B-chain or fragments, salts, solvates, derivatives, isomers or tautomers of the A-chain, the B-chain or both, provided that the dicarba analogue is not [A7,B7-(2,7-diaminosuberoyl]-des-(B26-B30)-insulin B25-amide.

US8748570B2 - United States
Period10 Jun 2014
Held atSyngene Limited, United Kingdom
Degree of RecognitionNational